At the ASGCT Policy Summit 2021, Nancy Bradish Myers shared these slides to help participants understand FDA’s accelerated approval standards and how they specifically apply to gene therapies. In addition, she highlighted the ongoing debate among sponsors, payors, and other FDA stakeholders who would like to “strengthen” the pathway.
Complete and submit the following form to download a PDF of the presentation.